Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:26 PM
Ignite Modification Date:
2025-12-24 @ 9:26 PM
NCT ID:
NCT01780532
Eligibility Criteria:
Inclusion Criteria:
* Patients must have a breast lesion/mass found at physical examination, mammography or ultrasound (US), that has not been surgically resected
* Patients may have any of the following characteristics:
* Taking hormones (e.g., contraceptives, hormone replacement therapy, post-cancer Tamoxifen)
* Breast implants
* Previous breast biopsy
* Previous breast surgery
* Previous breast cancer
* High risk of breast cancer (e.g., breast cancer susceptibility gene (BRCA) mutations, other gynecologic cancer)
* Ability to understand and the willingness to sign a written informed consent document
Exclusion Criteria:
* Patients who have had primary surgical excision of the suspicious finding
* Pregnant or lactating women
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT01780532
Study Brief:
Protocol Section:
NCT01780532